Hansberger Growth Investors’s Dr. Reddy's Laboratories RDY Stock Holding History

Hansberger Growth Investors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-346,610	Closed	-$2.78M	–	18
2017 Q1	$2.78M	Buy	346,610 +1,775	+0.5%	+$15.3K	3.25%	10
2016 Q4	$3.12M	Sell	344,835 -26,630	-7%	-$248K	3.99%	8
2016 Q3	$3.45M	Sell	371,465 -123,790	-25%	-$1.18M	2.6%	9
2016 Q2	$5.07M	Sell	495,255 -46,215	-9%	-$424K	3.94%	8
2016 Q1	$4.89M	Sell	541,470 -72,275	-12%	-$646K	3.3%	8
2015 Q4	$5.68M	Sell	613,745 -30,170	-5%	-$330K	3.98%	7
2015 Q3	$8.23M	Sell	643,915 -53,340	-8%	-$663K	5.89%	6
2015 Q2	$7.71M	Sell	697,255 -424,575	-38%	-$4.69M	5.26%	5
2015 Q1	$12.8M	Sell	1,121,830 -620,385	-36%	-$6.58M	4.96%	5
2014 Q4	$17.6M	Buy	+1,742,215	New	+$18.3M	5.45%	6

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hansberger Growth Investors's RDY Position: Q2 2017 in Review

Hansberger Growth Investors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2017, closing a stake of 346,610 shares — an estimated $2.78M sold.

Hansberger Growth Investors first reported a position in RDY in Q4 2014 and held it in 10 quarters. The position peaked at $17.6M in Q4 2014. 128 funds tracked by Wall St. Rank hold RDY as of Q2 2017.

Hansberger Growth Investors reported no remaining Dr. Reddy's Laboratories position as of Q2 2017 after selling out during the quarter.
Hansberger Growth Investors sold 346,610 Dr. Reddy's Laboratories shares in Q2 2017, an estimated $2.78M.
Hansberger Growth Investors first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 10 quarters.
Hansberger Growth Investors's Dr. Reddy's Laboratories position peaked at $17.6M in Q4 2014.
128 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2017.

Based on Hansberger Growth Investors's 13F filing for Q2 2017, filed 14 Aug 2017.